Category Archives: Medtonic Infuse

Featured Stories

Government Penalizes 721 Hospitals for High Rates of Infections, Injuries

Medicare is reducing payments to 721 hospitals, one out of every seven hospitals in the nation, for having high rates of “hospital-acquired” conditions (HAC.

Read More

Stryker Metal Hip Implant Component Recall Bad News for Makers of Metal-on-Metal Hip Replacement Devices

Stryker’s recent recall of two metal hip implant components, the Rejuvenate Modular and ABG II modular-neck hip stems, may have dealt a serious blow to one of the key arguments medical device manufacturers have made to defend their metal-on-metal hip replacements. Facing thousands of lawsuits, the makers of ...

Read More

Lawsuits over DePuy ASR Metal-on-Metal Hip Implants Continue to Mount

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be hit with lawsuits over recalled metal-on-metal DePuy ASR hip implants. Just yesterday, the national law firm of Parker Waichman LLP announced it had filed yet another DePuy ASR hip implant lawsuit, this time on behalf of a Virginia resident ...

Read More

Canadian Study Finds Actos Raises Bladder Cancer Risk by 22 Percent

Yet another study is confirming the association between the diabetes drug, Actos, and bladder cancer. This latest research, published today in the Canadian Medical Association Journal, found that taking Actos raised the risk of bladder cancer among diabetics by about one-fifth.

Read More

FDA Advisors Set to Examine Metal-on-Metal Hip Implant Safety Concerns

Thousands of people with metal-on-metal hip implant devices could soon get some answers from the U.S. Food & Drug Administration (FDA) about the dangers they face. Tomorrow, the agency will convene a panel of outside medical experts to examine the safety record of metal-on-metal hip replacements, and recommend the ...

Read More

Metal-on-Metal Hip Implant Lawyer Takes Issue with Statements Made by DePuy Orthpaedics Official During FDA Meeting

An attorney with a national law firm that represents victims of alleged metal-on-metal hip implant injuries has expressed dismay at some statements made last week regarding the regulation of all-metal hip replacement devices by an official with DePuy Orthopaedics. According to Daniel Burke, Senior Litigation Counsel at Parker ...

Read More

Canadian Warning Issued for Actos Bladder Cancer Side Effect Risk

Health Canada has become the most recent national drug regulator to issue a warning about Actos and bladder cancer. Last month, the agency warned that interim results from a 10-year-study indicated that patients taking Actos for more than a year faced an increased risk of bladder cancer. Health Canada also ...

Read More

Medtronic Infuse Lawsuit Alleges Off-Label Use Cause Painful Complications

A man in Louisiana has filed suit against Medtronic Inc. over injuries allegedly cause by off-label use of its Infuse Bone Graft product. The plaintiff, who received Infuse during transforaminal spinal lumbar fusion surgery, claims that the bone growth protein caused unwanted bone growth along his spine, worsening the back ...

Read More

Post -Tonsillectomy Morphine Life-Threatening in Children

Post -Tonsillectomy Morphine can be Life-Threatening in Children, Study Finds

A new study published in Pediatrics suggests that morphine can result in life-threatening respiratory problems when given to children after a tonsillectomy.

Read More

Stanford University Study: Medtronic Infuse Bone Graft Device Increases Cancer Risks

medtronic_infuse_cancer_risk

A new Stanford University study has found that use of Medtronic’s Infuse increases new cancer risks. According to a Stanford University study published in the September 4, 2013, edition of The Journal of Bone & Joint Surgery, a large dose—at … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse |

Medtronic Bid to Dismiss InFuse Case Denied

arizona_judge_rules_medtronic_infuse

Medtronic Inc.’s bid for preemption was just denied by a federal judge. The case involved the device maker’s highly controversial InFuse bone graft product. The Arizona judge rejected Medtronic’s arguments that federal law preempted a lawsuit brought over claims that … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse |

Judge Blocks Medtronic InFuse Suits, Plaintiffs to Re-File Cases Alleging Fraud

judge_rules_in_favor_of_medtronic

Although a lower court Illinois state court judge very recently denied device maker, Medtronic Inc.’s, bid to dismiss a lawsuit brought over its InFuse bone graft product, a Minneapolis judge did grant Medtronic’s motion to dismiss the InFuse claims there. … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse |

Industry Promises Increased Transparency, Medtronic InFuse Debacle Cited

drug_company_transparency

Some of the world’s largest drug makers have promised to release detailed information about their pharmaceutical products, such as Medtronic’s InFuse, to external researchers. While many are happy with the move, others point out that this might be a way … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Medtronic’s Motion to Dismiss InFuse Lawsuit Denied

infuse_lawsuit_goes_through

An Illinois state court judge just denied device maker, Medtronic Inc.’s, bid to dismiss a lawsuit brought over its InFuse bone graft product. The lawsuit included allegations that InFuse caused a patient to undergo additional surgery that led to permanent … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Pending Sunshine Act to Focus on Allegedly Fraudulent Financial Ties Between Physicians and Industry

sunshine_act_physicians

On August 1, the Physician Payment Sunshine Act provision of the Affordable Care Act will go into effect. The Act is meant to highlight allegedly bogus relationships between physicians and pharmaceutical firms and medical device manufacturers. As we’ve long stressed, … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Increased Transparency in Medicine Coming

medical_research_changes

When approved by the U.S Food and Drug Administration in 2002, Medtronic’s bone graft product, InFuse, was seen as a medical breakthrough. InFuse eliminated the need to remove patient bone from the hip in spinal fusions and could, instead, use … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Injured InFuse Users Working Toward Their Day in Court

medtronic_infuse_victims

Hundreds of people allegedly injured following procedures involving Medtronic’s InFuse are utilizing a different legal approach. The arguments planned include that the U.S. Food and Drug Administration (FDA) issued a warning in 2008 to physicians concerning “life-threatening complications” from unapproved … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Do Consumers Know the Risks of Medtronic InFuse? Are Consumers Aware of Safer Options?

medtronic_infuse_danger_alternatives

Medtronic’s bone graft product, InFuse, is a synthetic, or genetically engineered, recombinant human Bone Morphogenetic Protein (rhBMP-2) that was approved by the U.S. Food & Drug Administration (FDA) in 2002 for specific uses. Meant to stimulate spine growth in patients … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Medtronic Shareholders File Lawsuit Amid InFuse® Scandal

medtronic_shareholders_lawsuit

  Device maker, Medtronic, is the focus of another shareholder lawsuit over its InFuse® bone growth product. Shareholders filed the lawsuit against Medtronic and some of its shareholders accusing them of intentionally minimizing potential dangers associated with InFuse® so that … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.